Cleveland HeartLab Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Cleveland HeartLab Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10471
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cleveland HeartLab Inc (Cleveland HeartLab) is a clinical laboratory that provides cardiovascular testing services. The laboratory offers services such as cardiovascular risk assessment, novel diagnostic tests, inflammatory and other advanced biomarker testing, management and prevention of heart disease, cardiovascular treatment and intellectual property portfolio services. Its testing services comprise inflammation testing, fatty acids, harmone, genetics, hypertention and heart failure, thyroid function, anemia, routein panels, standard laboratory test, advanced lipid testing and other CV and metabolic testing services. Cleveland HeartLab offers testing services in the areas of advanced cholesterol assessment profile, alanine, amino transferase, albumin, aldolase, aldosterone, DHEA, cancer, cholesterol, oral glucose tolerance, blood, and other tests. The laboratory partners with academic and medical institutions. Cleveland HeartLab is headquartered in Cleveland, Ohio, the US.

Cleveland HeartLab Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cleveland HeartLab Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cleveland HeartLab Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Cleveland HeartLab Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cleveland HeartLab Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Cleveland HeartLab Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Cleveland HeartLab Inc, Medical Equipment, Deal Details 10
Asset Purchase 10
Cleveland HeartLab Acquires Mirisk Cardiovascular Disease Risk Assessment Tool from Stanford University School of Medicine 10
Venture Financing 11
Cleveland HeartLab Raises USD3 Million in Venture Financing 11
Cleveland HeartLab Raises US$14.7 Million In Venture Financing 12
Private Equity 14
Advantage Capital Partners Invests in Cleveland HeartLab 14
Partnerships 15
Cleveland Clinic Enters into Agreement with Procter & Gamble and Cleveland HeartLab 15
Acquisition 16
Quest Diagnostics Acquires Cleveland HeartLab from Cleveland Clinic and Advantage Capital 16
Cleveland HeartLab Inc – Key Competitors 18
Cleveland HeartLab Inc – Key Employees 19
Cleveland HeartLab Inc – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Product News 21
Nov 09, 2018: Quest Diagnostics to showcase new data at the American Heart Association 2018 Scientific Sessions 21
Mar 27, 2018: Inflammation Testing Prompts Care Changes Leading to Significantly Lower Levels in Patients with Increased Cardiovascular Risk Due to Diabetes or Pre-Diabetes 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Cleveland HeartLab Inc, Medical Equipment, Key Facts 2
Cleveland HeartLab Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Cleveland HeartLab Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cleveland HeartLab Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Cleveland HeartLab Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cleveland HeartLab Inc, Deals By Market, 2012 to YTD 2018 8
Cleveland HeartLab Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Cleveland HeartLab Acquires Mirisk Cardiovascular Disease Risk Assessment Tool from Stanford University School of Medicine 10
Cleveland HeartLab Raises USD3 Million in Venture Financing 11
Cleveland HeartLab Raises US$14.7 Million In Venture Financing 12
Advantage Capital Partners Invests in Cleveland HeartLab 14
Cleveland Clinic Enters into Agreement with Procter & Gamble and Cleveland HeartLab 15
Quest Diagnostics Acquires Cleveland HeartLab from Cleveland Clinic and Advantage Capital 16
Cleveland HeartLab Inc, Key Competitors 18
Cleveland HeartLab Inc, Key Employees 19

List of Figures
Cleveland HeartLab Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Cleveland HeartLab Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Cleveland HeartLab Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Cleveland HeartLab Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Cleveland HeartLab Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cleveland HeartLab Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Cleveland HeartLab Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cleveland HeartLab Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Cleveland HeartLab Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Toro Company:企業の戦略・SWOT・財務情報
    The Toro Company - Strategy, SWOT and Corporate Finance Report Summary The Toro Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Joint Stock Commercial Bank for Foreign Trade of Vietnam (VCB):企業の財務・戦略的SWOT分析
    Joint Stock Commercial Bank for Foreign Trade of Vietnam (VCB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the c …
  • Galectin Therapeutics Inc (GALT):企業の財務・戦略的SWOT分析
    Summary Galectin Therapeutics Inc (Galectin Therapeutics), formerly Pro-Pharmaceuticals Inc is a biotechnology company that discovers, develops and commercializes therapies for fibrotic disease and cancer. The company provides products such as GR-MD-02, GM-CT-01, and others. Its GR-MD-02 is a drug c …
  • Canacol Energy Ltd (CNE):企業の財務・戦略的SWOT分析
    Summary Canacol Energy Ltd (Canacol Energy) is an oil and gas company that explores and produces conventional and unconventional oil fields. The company operates oil and gas reserves in Caguan-Putumayo basin, Lower Magdalena basin, Llanos basin, Magdalena basin in Colombia; and Oriente basin in Ecua …
  • Touchstone Innovations plc (IVO):企業の財務・戦略的SWOT分析
    Summary Touchstone Innovations Plc (Touchstone Innovations), formerly Imperial Innovations Group Plc, a subsidiary of IP Group Plc, is a technology commercialization and investment company. The company creates, builds, and invests in early-stage pioneering technology companies and licensing opportun …
  • Nahar Industrial Enterprises Limited (NAHARINDUS):企業の財務・戦略的SWOT分析
    Nahar Industrial Enterprises Limited (NAHARINDUS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • China Biologic Products Inc (CBPO):製薬・医療:M&Aディール及び事業提携情報
    Summary China Biologic Products Inc (China Biologic) is a biopharmaceutical company that offers plasma collection, research and development, production, commercialization of biopharmaceutical products and development of treatment products. The company manufactures, develops, and markets biologic pro …
  • Xellia Pharmaceuticals ApS-製薬・医療分野:企業M&A・提携分析
    Summary Xellia Pharmaceuticals ApS (Xellia), a subsidiary of Novo A/S is a healthcare products provider that offers fermented and semi-synthetic APIs and injectable finished dosage forms. The company offers strain and fermentation development with bacteria and fungi. It provides injectable products …
  • Brenntag AG:企業のM&A・事業提携・投資動向
    Brenntag AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Brenntag AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Suntory Beverage & Food Limited:企業の戦略・SWOT・財務情報
    Suntory Beverage & Food Limited - Strategy, SWOT and Corporate Finance Report Summary Suntory Beverage & Food Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Matrix IT Ltd (MTRX):企業の財務・戦略的SWOT分析
    Matrix IT Ltd (MTRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Cyclopharm Ltd (CYC):企業の財務・戦略的SWOT分析
    Cyclopharm Ltd (CYC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Public Financial Holdings Limited (626):企業の財務・戦略的SWOT分析
    Public Financial Holdings Limited (626) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Cheng Loong Corp:企業の戦略・SWOT・財務情報
    Cheng Loong Corp - Strategy, SWOT and Corporate Finance Report Summary Cheng Loong Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Alere Toxicology Plc:企業の戦略的SWOT分析
    Alere Toxicology Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Ingenico SA:戦略・SWOT・企業財務分析
    Ingenico SA - Strategy, SWOT and Corporate Finance Report Summary Ingenico SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Etablissementen Franz Colruyt NV (COLR):企業の財務・戦略的SWOT分析
    Etablissementen Franz Colruyt NV (COLR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Shanghai Pharmaceutical Co Ltd (601607):医療機器:M&Aディール及び事業提携情報
    Summary Shanghai Pharmaceutical Co Ltd (Shanghai Pharma) is a manufacturer, retailer, wholesaler and distributor of healthcare products. The company carries out the research and development, manufacture and sale of pharmaceutical products for treating HER2 positive advanced breast cancer, systemic a …
  • Verona Pharma Plc (VRP):製薬・医療:M&Aディール及び事業提携情報
    Summary Verona Pharma Plc (Verona Pharma) is a clinical-stage biotechnology company, which focuses on the research, discovery and development of first-in-class therapeutic drugs for the treatment of chronic respiratory and inflammatory diseases. The company's lead candidate, RPL554 is a bronchodilat …
  • Hokuto Bank Ltd:企業の戦略・SWOT・財務情報
    Hokuto Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary Hokuto Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆